Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Targeted tumor killing via an intracellular antibody against erbB-2.
J Deshane, … , M Kay, D T Curiel
J Deshane, … , M Kay, D T Curiel
Published December 1, 1995
Citation Information: J Clin Invest. 1995;96(6):2980-2989. https://doi.org/10.1172/JCI118370.
View: Text | PDF
Research Article Article has an altmetric score of 9

Targeted tumor killing via an intracellular antibody against erbB-2.

  • Text
  • PDF
Abstract

Specific killing of erbB-2-overexpressing tumor cells can be achieved using expression of an intracellular antibody directed against the erbB-2 oncoprotein. We have developed a strategy using a recombinant adenovirus encoding an anti-erbB-2 single chain antibody to achieve targeted tumor cell killing in vivo and can show significantly prolonged survival of animals carrying a human ovarian carcinoma tumor burden within their peritoneal cavities. This strategy of gene therapy for ovarian carcinoma offers the potential to achieve highly specific, targeted killing of human tumor cells and thus establishes the rationale to undertake human clinical trials on this basis.

Authors

J Deshane, G P Siegal, R D Alvarez, M H Wang, M Feng, G Cabrera, T Liu, M Kay, D T Curiel

×

Total citations by year

Year: 2021 2018 2017 2016 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1994 1983 Total
Citations: 2 3 2 1 1 1 2 2 1 1 3 3 4 3 6 5 2 6 7 7 8 3 1 1 75
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (75)

Title and authors Publication Year
Modeling Pharmacokinetics and Pharmacodynamics of Therapeutic Antibodies: Progress, Challenges, and Future Directions
Y Tang, Y Cao
Pharmaceutics 2021
A Small Virus to Deliver Small Antibodies: New Targeted Therapies Based on AAV Delivery of Nanobodies
N Silva-Pilipich, C Smerdou, L Vanrell
Microorganisms 2021
Neutralizing Anti-Hemagglutinin Monoclonal Antibodies Induced by Gene-Based Transfer Have Prophylactic and Therapeutic Effects on Influenza Virus Infection
T Yamazaki, J Chiba, S Akashi-Takamura
Human vaccines 2018
Antibody Engineering
T Böldicke
2018
Targeted Intracellular Delivery of Antibodies: The State of the Art
TA Slastnikova, AV Ulasov, AA Rosenkranz, AS Sobolev
Frontiers in pharmacology 2018
HCaRG/COMMD5 inhibits ErbB receptor-driven renal cell carcinoma
H Matsuda, CG Campion, K Fujiwara, J Ikeda, S Cossette, T Verissimo, M Ogasawara, L Gaboury, K Saito, K Yamaguchi, S Takahashi, M Endo, N Fukuda, M Soma, P Hamet, J Tremblay
Oncotarget 2017
State of play and clinical prospects of antibody gene transfer
K Hollevoet, PJ Declerck
Journal of Translational Medicine 2017
The antitumor efficacy of a novel adenovirus-mediated anti-p21Ras single chain fragment variable antibody on human cancers in vitro and in vivo
JL Yang, XY Pan, WX Zhao, QC Hu, F Ding, Q Feng, GY Li, Y Luo
International journal of oncology 2016
A bispecific transmembrane antibody simultaneously targeting intra- and extracellular epitopes of the epidermal growth factor receptor inhibits receptor activation and tumor cell growth: Bispecific transmembrane antibody targeting EGFR
N Müller, C Hartmann, S Genßler, J Koch, A Kinner, M Grez, WS Wels
International Journal of Cancer 2013
The use of phage display to generate conformation-sensor recombinant antibodies
A Haque, NK Tonks
Nature Protocols 2012
State of the art in tumor antigen and biomarker discovery
K Even-Desrumeaux, D Baty, P Chames
Cancers 2011
Analysis of promoters and expression-targeted gene therapy optimization based on doubling time and transfectability
GL Dobek, X Zhang, DA Balazs, WT Godbey
The FASEB Journal 2011
Monoclonal Antibody and Peptide-Targeted Radiotherapy of Cancer
K Ottolino-Perry, JA McCart
Monoclonal Antibody and Peptide-Targeted Radiotherapy of Cancer 2010
Persistent expression of biologically active anti-HER2 antibody by AAVrh.10-mediated gene transfer
G Wang, J Qiu, R Wang, A Krause, JL Boyer, NR Hackett, RG Crystal
Cancer Gene Therapy 2010
Intrabody and Parkinson's disease
C Zhou, S Przedborski
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2009
Therapeutic Antibodies
Y Chernajovsky, A Nissim
2008
Adenoviral vectors for gene therapy
JT Douglas
Molecular Biotechnology 2007
Novel antibodies as anticancer agents
I Zafir-Lavie, Y Michaeli, Y Reiter
Oncogene 2007
Gene therapy of gynaecological diseases
A Kanerva, M Raki, A Hemminki
Expert Opinion on Biological Therapy 2007
Intra-arterial adenoviral mediated tumor transfection in a novel model of cancer gene therapy
G Cabrera, SL Porvasnik, PE DiCorleto, M Siemionow, CK Goldman
Molecular Cancer 2006
Inhibition of Papillomavirus Protein Function in Cervical Cancer Cells by Intrabody Targeting
H Griffin, R Elston, D Jackson, K Ansell, M Coleman, G Winter, J Doorbar
Journal of Molecular Biology 2006
Gene Transfer Approaches for Gynecological Diseases
M Raki, DT Rein, A Kanerva, A Hemminki
Molecular Therapy 2006
Potential applications of intracellular antibodies (intrabodies) in stem cell therapeutics
BC Heng, DM Kemeny, H Liu, T Cao
Journal of Cellular and Molecular Medicine 2005
Making cell-permeable antibodies (Transbody) through fusion of protein transduction domains (PTD) with single chain variable fragment (scFv) antibodies: Potential advantages over antibodies expressed within the intracellular environment (Intrabody)
BC Heng, T Cao
Medical Hypotheses 2005
Phenotypic knockout of VEGF-R2 and Tie-2 with an intradiabody reduces tumor growth and angiogenesis in vivo
N Jendreyko, M Popkov, C Rader, CF 3rd
Proceedings of the National Academy of Sciences 2005
Cancer Gene Therapy
M Yamamoto, DT Curiel
Technology in cancer research & treatment 2005
Antibodies and gene therapy: teaching old ‘magic bullets’ new tricks
L Sanz, B Blanco, L Álvarez-Vallina
Trends in Immunology 2004
Intrabodies: production and promise
MR Stocks
Drug Discovery Today 2004
Ablating CAR and Integrin Binding in Adenovirus Vectors Reduces Nontarget Organ Transduction and Permits Sustained Bloodstream Persistence Following Intraperitoneal Administration
M Akiyama
Molecular Therapy 2004
Inhibition of endothelial cell surface expression of vascular endothelial growth factor receptor-2 using an intrabody strategy
Yurong Yang Wheeler, Timothy E. Kute, Mark C. Willingham, Si-Yi Chen, David C. Sane
The FASEB Journal 2003
Intracellular antibodies and challenges facing their use as therapeutic agents
MN Lobato, TH Rabbitts
Trends in Molecular Medicine 2003
Gene and Cell Therapy: Therapeutic Mechanisms and Strategies, Second Edition, Revised and Expanded
H Heslop, M Brenner, C Bollard
Gene and Cell Therapy: Therapeutic Mechanisms and Strategies, Second Edition, Revised and Expanded 2003
Intradiabodies, Bispecific, Tetravalent Antibodies for the Simultaneous Functional Knockout of Two Cell Surface Receptors
N Jendreyko, M Popkov, RR Beerli, J Chung, DB McGavern, C Rader, CF Barbas
The Journal of biological chemistry 2003
Intrabody and intrakine strategies for molecular therapy
YY Wheeler, SY Chen, DC Sane
Molecular Therapy 2003
Abrogation of hepatitis C virus NS3 helicase enzymatic activity by recombinant human antibodies
O Artsaenko, K Tessmann, M Sack, D Häussinger, T Heintges
Journal of General Virology 2003
Characterization of anti-cyclin E single-chain Fv antibodies and intrabodies in breast cancer cells: enhanced intracellular stability of novel sFv–Fc intrabodies
RW Strube, SY Chen
Journal of Immunological Methods 2002
Cloning and molecular characterization of human high affinity antibody fragments against Hepatitis C virus NS3 helicase
K Tessmann, A Erhardt, D Häussinger, T Heintges
Journal of Virological Methods 2002
Gene Therapy in Lung Disease
K Amin
Gene Therapy in Lung Disease 2002
Intratumoral administration of an adenovirus expressing a kinase dead form of ErbB-2 inhibits tumor growth
K Palmer, N Sharan, P Emtage, J Gauldie, WJ Muller, Y Wan
Gene Therapy 2002
Genetically Engineered Intracellular Single-Chain Antibodies in Gene Therapy
G Bilbao, JL Contreras, DT Curiel
Molecular Biotechnology 2002
Intracellular Stability of Anti-caspase-3 Intrabodies Determines Efficacy in Retargeting the Antigen
A Rajpal, TG Turi
The Journal of biological chemistry 2001
Thoracic Oncology
DS Ettinger
2001
Using a Tropism-Modified Adenoviral Vector to Circumvent Inhibitory Factors in Ascites Fluid
JL Blackwell, H Li, J Gomez-Navarro, I Dmitriev, V Krasnykh, CA Richter, DR Shaw, RD Alvarez, DT Curiel, TV Strong
Human Gene Therapy 2000
Role of HER2 gene overexpression in breast carcinoma
S M�nard, E Tagliabue, M Campiglio, SM Pupa
Journal of Cellular Physiology 2000
Sensitivity of c‐erbB Positive Cells to a Ligand Toxin and Its Utility in Purging Breast Cancer Cells from Peripheral Blood Stem Cell (PBSC) Collections
M Keir, R Fiddes, JC Biggs, PP Kearney
Stem Cells 2000
Adenovirus-mediated ribozyme targeting of HER-2/neu inhibits in vivo growth of breast cancer cells
T Suzuki, B Anderegg, T Ohkawa, A Irie, O Engebraaten, M Halks-Miller, PS Holm, DT Curiel, M Kashani-Sabet, KJ Scanlon
Gene Therapy 2000
Gene Therapy for Lung Cancer
PJ Mosca, MA Morse, TA D'Amico, J Crawford, HK Lyerly
Clinical Lung Cancer 2000
Molecular and Genetic Aspects of Lung Cancer
WN Rom, JG Hay, TC Lee, Y Jiang, KM Tchou-Wong
American journal of respiratory and critical care medicine 2000
Advances in cancer gene therapy
G Bilbao, JL Contreras, DT Curiel
Expert Opinion on Therapeutic Patents 1999
Rapid production of specific vaccines for lymphoma by expression of the tumor-derived single-chain Fv epitopes in tobacco plants
AA McCormick, MH Kumagai, K Hanley, TH Turpen, I Hakim, LK Grill, D Tusé, S Levy, R Levy
Proceedings of the National Academy of Sciences 1999
Extended half-life and elevated steady-state level of a single-chain Fv intrabody are critical for specific intracellular retargeting of its antigen, caspase-7
Q Zhu, C Zeng, A Huhalov, J Yao, TG Turi, D Danley, T Hynes, Y Cong, D DiMattia, S Kennedy, G Daumy, E Schaeffer, WA Marasco, JS Huston
Journal of Immunological Methods 1999
Characterization and Binding of Intracellular Antibody Fragments to the Hepatitis C Virus Core Protein1,2
T Heintges, J Putlitz, JR Wands
Biochemical and Biophysical Research Communications 1999
Gene therapy for carcinoma of the breast: Genetic ablation strategies
DT Curiel
Breast Cancer Research 1999
Suppression of the c-erbB-2 gene product decreases transformation abilities but not the proliferation and secretion of proteases of SK-OV-3 ovarian cancer cells
K Wiechen, S Karaaslan, A Turzynski, M Dietel
British Journal of Cancer 1999
A role for intracellular immunization in chemosensitization of tumor cells?
A Piché, C Rancourt
Gene Therapy 1999
c-erbB-2 as a target for immunotherapy
S Eccles
Expert Opinion on Investigational Drugs 1998
The Genetics of Ovarian Cancer
SE DePasquale, A Giordano, AE Donnenfeld
Obstetrical & Gynecological Survey 1998
Genetically Engineered Antibodies in Gene Transfer and Gene Therapy
M Pelegrin, M Marin, D Noël, M Piechaczyk
Human Gene Therapy 1998
Establishment and characterization of a new mammary adenocarcinoma cell line derived from MMTV neu transgenic mice
MG Sacco, L Gribaldo, O Barbieri, G Turchi, I Zucchi, A Collotta, L Bagnasco, D Barone, C Montagna, A Villa, E Marafante, P Vezzoni
Breast Cancer Research and Treatment 1998
GENE THERAPY FOR LUNG CANCER
SM Dubinett, PW Miller, S Sharma, RK Batra
Hematology/Oncology Clinics of North America 1998
Radiosensitization mediated by a transfected Anti-erbB-2 single-chain antibody in vitro and in vivo
MA Stackhouse, DJ Buchsbaum, WE Grizzle, SJ Bright, CC Olsen, S Kancharla, MS Mayo, DT Curiel
International journal of radiation oncology, biology, physics 1998
Intracellular Expression of the Anti-erbB-2 sFv N29 Fails to Accomplish Efficient Target Modulation
JE Grim, GP Siegal, RD Alvarez, DT Curiel
Biochemical and Biophysical Research Communications 1998
Transductional Efficacy and Safety of an Intraperitoneally Delivered Adenovirus Encoding an Anti-erbB-2 Intracellular Single-Chain Antibody for Ovarian Cancer Gene Therapy
J Deshane, GP Siegal, M Wang, M Wright, RP Bucy, RD Alvarez, DT Curiel
Gynecologic Oncology 1997
A Novel Gene Therapy Strategy for Elimination of Prostate Carcinoma Cells from Human Bone Marrow
M Kim, M Wright, J Deshane, MA Accavitti, A Tilden, M Saleh, WP Vaughan, MH Carabasi, MD Rogers, RD Hockett, WE Grizzle, DT Curiel
Human Gene Therapy 1997
Conditionally replicative adenoviruses for cancer therapy
C Rancourt
Advanced Drug Delivery Reviews 1997
Tumor localization of a radiolabeled bombesin analogue in mice bearing human ovarian tumors induced to express the gastrin-releasing peptide receptor by an adenoviral vector
BE Rogers, DT Curiel, MS Mayo, KK Laffoon, SJ Bright, DJ Buchsbaum
Cancer 1997
Antibody engineering
MS Hayden, LK Gilliland, JA Ledbetter
Current Opinion in Immunology 1997
Gene therapy strategies for carcinoma of the breast
JM Ruppert, M Wright, M Rosenfeld, J Grushcow, G Bilbao, DT Curiel, TV Strong
Breast Cancer Research and Treatment 1997
Gene Therapy for Lung Cancer and Mesothelioma
SM Albelda
Chest 1997
Intracellular Antibodies
A Cattaneo, S Biocca
1997
The maturation of human gene therapy
T Friedmann
Acta Paediatrica 1996
Section Review Oncologic, Endocrine & Metabolic: Gene therapy for cancer therapeutics
G Bilbao, DT Curiel
Expert Opinion on Therapeutic Patents 1996
Adenoviral-mediated delivery of herpes simplex virus thymidine kinase results in tumor reduction and prolonged survival in a SCID mouse model of human ovarian carcinoma
ME Rosenfeld, M Wang, GP Siegal, RD Alvarez, G Mikheeva, V Krasnykh, DT Curiel
Journal of Molecular Medicine 1996
Advances in Pharmacology
B Drenger, Y Ginosar, Y Gozal
Advances in Pharmacology 1994
New Comprehensive Biochemistry
S Yamamoto
New Comprehensive Biochemistry 1983

← Previous 1 2 3 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 7 patents
22 readers on Mendeley
See more details